Skip to content

Study · Animal study (in vivo) · mouse · 1989

1 result

Age-dependent antileukemic action and suppression of immune response by 1,4-benzoquinone-guanylhydrazone-thiosemicarbazone (ambazone) in mice.

Baumgart J, Wisniewski HG, Amlacher R, Zhukovskaya NV, Rentz E

Neoplasma1 Jan 1989Cited by 2 (Europe PMC)

PMID2770926 (opens in a new tab)PepBankPUB-02770926
Publisher pageAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In young and old leukemia P388-bearing mice, adding thymalin to ambazone failed to improve the antileukemic effect compared with ambazone alone.

    In plain wordsIn young and old leukemia-bearing mice, adding thymalin to ambazone did not improve the antileukemic effect compared with ambazone alone.

    Peptide
    Thymalin
    Outcome
    No significant changeAntileukemic effect
    Study

    mousen: not reported in source

    Young and old leukemia P388-bearing mice
    Comparator
    Ambazone treatment
    Outcome group
    Tumor growth · Cancer
    Studied dose
    Dose not stated

    Source sentences

    Summary
    A combined treatment with ambazone and immunomodulators (thymalin or a splenopentin derivative) failed to improve the antileukemic effect in young and old leukemia P388-bearing mice.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.